UniProt Q9HC77
Centromere protein J (Q9HC77)
Centromere protein J (UniProt Q9HC77): 6 experimental structures and 1 predicted model on GenesisL1, 7 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- Q9HC77
- Protein
- Centromere protein J
- Experimental structures
- 6
- Predicted models
- 1
- Pockets
- 7 · 1 record with a druggable one
Structures
7 records of Q9HC77 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 5EIB | Crystal structure of CPAP PN2-3 C-terminal loop-helix in complex with DARPin-tubulin | x-ray diffraction | F | — | 3 (best 0.41) |
| 5EIB | Crystal structure of cpap PN2-3 C-terminal loop-helix in complex with darpin-tubulin | x-ray diffraction | F | — | — |
| 5ITZ | Crystal structure of the SAC domain of CPAP in a complex with Tubulin and Darpin | x-ray diffraction | D | — | — |
| 5ITZ | Crystal structure of the sac domain of cpap in a complex with tubulin and darpin | x-ray diffraction | D | — | — |
| 7Q1E | CPAP:TUBULIN:IIH5 alpharep complex | x-ray diffraction | P | — | — |
| 7Z0G | CPAP:TUBULIN:IE5 alpharep complex P1 space group | x-ray diffraction | P, U | — | 4 (best 0.83) |
| Q9HC77 | AlphaFold monomer V2.0 prediction for centromere protein J (Q9HC77) | predicted | A | — | — |
Experiment against prediction
- 7Q1E chain P against the predicted model Q9HC77: TM-score 0.51, RMSD 2.19 Å
- 7Z0G chain P against the predicted model Q9HC77: TM-score 0.45, RMSD 2.36 Å
- 7Z0G chain U against the predicted model Q9HC77: TM-score 0.40, RMSD 2.11 Å
- 5EIB chain F against the predicted model Q9HC77: TM-score 0.32, RMSD 1.69 Å
- 5EIB chain F against the predicted model Q9HC77: TM-score 0.32, RMSD 1.69 Å
- 5ITZ chain D against the predicted model Q9HC77: TM-score 0.30, RMSD 1.33 Å
- 5ITZ chain D against the predicted model Q9HC77: TM-score 0.30, RMSD 1.33 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.